Meeder Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.2M Buy
144,080
+25,604
+22% +$5.96M 2.02% 10
2025
Q4
$24.5M Buy
118,476
+110,160
+1,325% +$21.8M 1.32% 15
2025
Q3
$1.54M Sell
8,316
-37,622
-82% -$6.45M 0.09% 110
2025
Q2
$7.02M Sell
45,938
-32,019
-41% -$4.92M 0.43% 50
2025
Q1
$12.9M Buy
77,957
+54,512
+233% +$8.53M 0.87% 22
2024
Q4
$3.39M Sell
23,445
-180,717
-89% -$28M 0.24% 65
2024
Q3
$33.1M Sell
204,162
-42,716
-17% -$6.81M 2.21% 12
2024
Q2
$36.1M Buy
246,878
+114,022
+86% +$17M 2.53% 9
2024
Q1
$21M Buy
132,856
+101,683
+326% +$16.2M 1.33% 18
2023
Q4
$4.89M Sell
31,173
-92,845
-75% -$14.2M 0.38% 68
2023
Q3
$19.3M Buy
124,018
+67,987
+121% +$11.2M 1.52% 14
2023
Q2
$9.27M Sell
56,031
-103,217
-65% -$16.7M 0.67% 34
2023
Q1
$24.7M Buy
159,248
+64,004
+67% +$10.3M 1.97% 8
2022
Q4
$16.8M Sell
95,244
-61,209
-39% -$10.6M 1.47% 11
2022
Q3
$25.6M Buy
156,453
+5,500
+4% +$931K 1.47% 11
2022
Q2
$26.8M Buy
150,953
+1,541
+1% +$275K 1.56% 11
2022
Q1
$26.5M Buy
+149,412
New +$25.4M 1.29% 14
2021
Q4
Sell
-146,930
Closed -$23.7M 1754
2021
Q3
$23.7M Sell
146,930
-5,205
-3% -$888K 1.24% 12
2021
Q2
$25.1M Buy
152,135
+2,179
+1% +$361K 1.17% 16
2021
Q1
$24.6M Buy
149,956
+131,597
+717% +$21.3M 1.26% 11
2020
Q4
$2.89M Sell
18,359
-132,443
-88% -$19.5M 0.64% 25
2020
Q3
$22.5M Buy
150,802
+11,369
+8% +$1.68M 1.45% 10
2020
Q2
$19.6M Buy
139,433
+26,968
+24% +$3.93M 1.28% 10
2020
Q1
$14.7M Buy
112,465
+3,218
+3% +$457K 1.15% 11
2019
Q4
$15.9M Sell
109,247
-1,417
-1% -$192K 0.97% 13
2019
Q3
$14.3M Buy
110,664
+974
+0.9% +$128K 0.95% 14
2019
Q2
$15.3M Buy
109,690
+10,927
+11% +$1.51M 1.07% 12
2019
Q1
$13.8M Buy
98,763
+507
+0.5% +$67.9K 1.09% 11
2018
Q4
$12.7M Buy
98,256
+22,157
+29% +$3.09M 1.13% 12
2018
Q3
$10.5M Buy
76,099
+19,318
+34% +$2.57M 0.79% 26
2018
Q2
$6.89M Sell
56,781
-419
-0.7% -$52.3K 0.59% 42
2018
Q1
$7.33M Sell
57,200
-9,327
-14% -$1.26M 0.68% 27
2017
Q4
$9.29M Buy
66,527
+512
+0.8% +$71.3K 0.79% 20
2017
Q3
$8.58M Sell
66,015
-25,096
-28% -$3.33M 0.93% 12
2017
Q2
$12.1M Buy
91,111
+7,975
+10% +$1.02M 1.15% 12
2017
Q1
$10.4M Sell
83,136
-23,799
-22% -$2.84M 0.93% 14
2016
Q4
$12.3M Buy
106,935
+10,264
+11% +$1.19M 1.18% 12
2016
Q3
$11.4M Sell
96,671
-7,318
-7% -$888K 0.97% 14
2016
Q2
$12.6M Sell
103,989
-1,854
-2% -$211K 1.18% 15
2016
Q1
$11.5M Buy
105,843
+276
+0.3% +$28.6K 1.08% 15
2015
Q4
$10.8M Buy
105,567
+53,769
+104% +$5.41M 0.98% 17
2015
Q3
$4.83M Sell
51,798
-62,235
-55% -$6.02M 0.47% 48
2015
Q2
$11.1M Buy
114,033
+31,647
+38% +$3.17M 1.13% 11
2015
Q1
$8.29M Buy
82,386
+2,497
+3% +$254K 0.89% 13
2014
Q4
$8.35M Buy
79,889
+9,498
+13% +$1M 1.06% 13
2014
Q3
$7.5M Buy
70,391
+32,148
+84% +$3.33M 1.1% 24
2014
Q2
$4M Buy
38,243
+135
+0.4% +$13.6K 0.59% 49
2014
Q1
$3.74M Buy
38,108
+19,405
+104% +$1.8M 0.61% 53
2013
Q4
$1.71M Buy
18,703
+13,490
+259% +$1.24M 0.29% 93
2013
Q3
$452K Buy
5,213
+180
+4% +$16.1K 0.09% 171
2013
Q2
$432K Buy
+5,033
New +$427K 0.09% 169

Other funds holding JNJ

Meeder Asset Management's JNJ Position: Q1 2026 in Review

Meeder Asset Management increased its Johnson & Johnson (JNJ) stake by 22% in Q1 2026, buying an estimated $5.96M and bringing the position to 144,080 shares worth $35.2M. The position accounts for 2.02% of the portfolio, ranked #10.

Meeder Asset Management first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $36.1M in Q2 2024. 4,621 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Meeder Asset Management held 144,080 shares of Johnson & Johnson worth $35.2M as of Q1 2026.
  • Meeder Asset Management bought 25,604 Johnson & Johnson shares in Q1 2026, an estimated $5.96M.
  • Johnson & Johnson made up 2.02% of Meeder Asset Management's portfolio in Q1 2026, its #10 holding.
  • Meeder Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • Meeder Asset Management's Johnson & Johnson position peaked at $36.1M in Q2 2024.
  • 4,621 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.